Epigenetic regulation of the latency-associated region of Marek's disease virus in tumor-derived T-cell lines and primary lymphoma

Journal of Virology

Volumn 86, Issue 3, 2012, Pages 1683-1695

  Brown, Andrew C ^a,b   Nair, Venugopal ^b   Allday, Martin J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; HETERODIMER; PROTEIN C JUN; TRICHOSTATIN A; UNTRANSLATED RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EPIGENETICS; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC REGULATION; HISTONE ACETYLATION; HISTONE MODIFICATION; ICP4 GENE; MARDIVIRUS; MAREK DISEASE; MEQ GENE; NONHUMAN; PP38 GENE; PRIORITY JOURNAL; T CELL LYMPHOMA; VIRUS GENE;

ANIMALS; BASE SEQUENCE; BIRDS; CELL LINE; CELL LINE, TUMOR; DNA METHYLATION; DNA PRIMERS; EPIGENESIS, GENETIC; HUMANS; LYMPHOMA; MARDIVIRUS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; VIRUS LATENCY;

GALLID HERPESVIRUS 2;

EID: 84857073356     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06113-11     Document Type: Article

References (57)

1. Anderson AS, Francesconi A, Morgan RW. 1992. Complete nucleotide sequence of the Marek's disease virus ICP4 gene. Virology 189:657-667.
2. Anobile JM, et al. 2006. Nuclear localization and dynamic properties of the Marek's disease virus oncogene products Meq and Meq/vIL8. J. Virol. 80:1160-1166.
3. Beisel C, Paro R. 2011. Silencing chromatin: comparing modes and mechanisms. Nat. Rev. Genet. 12:123.
4. Bernstein BE, et al. 2006. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125:315-326.
5. Biggs PM. 1997. The Leeuwenhoek Lecture, 1997. Marek's disease herpesvirus: oncogenesis and prevention. Philos. Trans. R. Soc. Lond. B Biol. Sci. 352:1951-1962.
6. Bloom DC, Giordani NV, Kwiatkowski DL. 2010. Epigenetic regulation of latent HSV-1 gene expression. Biochim. Biophys. Acta 1799:246-256.
7. Brookes E, Pombo A. 2009. Modifications of RNA polymerase II are pivotal in regulating gene expression states. EMBO Rep. 10:1213-1219.
8. Brown AC, et al. 2006. Interaction of MEQ protein and C-terminalbinding protein is critical for induction of lymphomas by Marek's disease virus. Proc. Natl. Acad. Sci. U. S. A. 103:1687-1692.
9. Brown AC, et al. 2009. Homodimerization of the Meq viral oncoprotein is necessary for induction of T-cell lymphoma by Marek's disease virus. J. Virol. 83:11142-11151.
10. Burnside J, et al. 2006. Marek's disease virus encodes microRNAs that map to meq and the latency-associated transcript. J. Virol. 80:8778-8786.
11. Cantello JL, Anderson AS, Morgan RW. 1994. Identification of latencyassociated transcripts that map antisense to the ICP4 homolog gene of Marek's disease virus. J. Virol. 68:6280-6290.
12. Cantello JL, Parcells MS, Anderson AS, Morgan RW. 1997. Marek's disease virus latency-associated transcripts belong to a family of spliced RNAs that are antisense to the ICP4 homolog gene. J. Virol. 71:1353-1361.
13. Chen XB, Sondermeijer PJ, Velicer LF. 1992. Identification of a unique Marek's disease virus gene which encodes a 38-kilodalton phosphoprotein and is expressed in both lytically infected cells and latently infected lymphoblastoid tumor cells. J. Virol. 66:85-94.
14. Cui X, Lee LF, Reed WM, Kung H-J, Reddy SM. 2004. Marek's disease virus-encoded vIL-8 gene is involved in early cytolytic infection but dispensable for establishment of latency. J. Virol. 78:4753-4760.
15. Delecluse HJ, Hammerschmidt W. 1993. Status of Marek's disease virus in established lymphoma cell lines: herpesvirus integration is common. J. Virol. 67:82-92.
16. Delecluse HJ, Schüller S, Hammerschmidt W. 1993. Latent Marek's disease virus can be activated from its chromosomally integrated state in herpesvirus-transformed lymphoma cells. EMBO J. 12:3277-3286.
17. Ding J, Cui Z, Lee LF. 2007. Marek's disease virus unique genes pp38 and pp24 are essential for transactivating the bi-directional promoters for the 1.8 kb mRNA transcripts. Virus Genes 35:643-650.
18. Epstein MA. 2001. Historical background. Philos. Trans. R. Soc. Lond. B Biol. Sci. 356:413-420.
19. Fragnet L, Blasco MA, Klapper W, Rasschaert D. 2003. The RNA subunit of telomerase is encoded by Marek's disease virus. J. Virol. 77: 5985-5996.
20. Gilley D, Blackburn EH. 1999. The telomerase RNA pseudoknot is critical for the stable assembly of a catalytically active ribonucleoprotein. Proc. Natl. Acad. Sci. U. S. A. 96:6621-6625.
21. Gimeno IM, et al. 2005. The pp38 gene of Marek's disease virus (MDV) is necessary for cytolytic infection of B cells and maintenance of the transformed state but not for cytolytic infection of the feather follicle epithelium and horizontal spread of MDV. J. Virol. 79:4545-4549.
22. Goodman RH, Smolik S. 2000. CBP/p300 in cell growth, transformation, and development. Genes Dev. 14:1553-1577.
23. Günther T, Grundhoff A. 2010. The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes. PLoS Pathog. 6:e1000935.
24. Kaufer BB, Jarosinski KW, Osterrieder N. 2011. Herpesvirus telomeric repeats facilitate genomic integration into host telomeres and mobilization of viral DNA during reactivation. J. Exp. Med. 208:605-615.
25. Levy AM, et al. 2003. Characterization of the chromosomal binding sites and dimerization partners of the viral oncoprotein Meq in Marek's disease virus-transformed T cells. J. Virol. 77:12841-12851.
26. Li DS, Pastorek J, Zelník V, Smith GD, Ross LJ. 1994. Identification of novel transcripts complementary to the Marek's disease virus homologue of the ICP4 gene of herpes simplex virus. J. Gen. Virol. 75:1713-1722.
27. Liu JL, Kung HJ. 2000. Marek's disease herpesvirus transforming protein MEQ: a c-Jun analogue with an alternative life style. Virus Genes 21: 51-64.
28. Liu JL, et al. 1999. MEQ and V-IL8: cellular genes in disguise? Acta Virol. 43:94-101.
29. Liu JL, Ye Y, Lee LF, Kung HJ. 1998. Transforming potential of the herpesvirus oncoprotein MEQ: morphological transformation, serumindependent growth, and inhibition of apoptosis. J. Virol. 72:388-395.
30. Lupiani B, et al. 2004. Marek's disease virus-encoded Meq gene is involved in transformation of lymphocytes but is dispensable for replication. Proc. Natl. Acad. Sci. U. S. A. 101:11815-11820.
31. Nair V. 2004. Successful control of Marek's disease by vaccination. Dev. Biol. (Basel) 119:147-154.
32. Nazerian K, et al. 1977. A nonproducer T lymphoblastoid cell line from Marek's disease transplantable tumor (JMV). Avian Dis. 21:69-76.
33. Ohlsson R, Lobanenkov V, Klenova E. 2010. Does CTCF mediate between nuclear organization and gene expression? Bioessays 32:37-50.
34. Parcells MS, Arumugaswami V, Prigge JT, Pandya K, Dienglewicz RL. 2003. Marek's disease virus reactivation from latency: changes in gene expression at the origin of replication. Poult. Sci. 82:893-898.
35. Parcells MS, et al. 2001. Marek's disease virus (MDV) encodes an interleukin-8 homolog (vIL-8): characterization of the vIL-8 protein and a vIL-8 deletion mutant MDV. J. Virol. 75:5159-5173.
36. Parelho V, et al. 2008. Cohesins functionally associate with CTCF on mammalian chromosome arms. Cell 132:422-433.
37. Paschos K, Allday MJ. 2010. Epigenetic reprogramming of host genes in viral and microbial pathogenesis. Trends Microbiol. 18:439-447.
38. Paschos K, et al. 2009. Epstein-Barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim. PLoS Pathog. 5:e1000492.
39. Phillips JE, Corces VG. 2009. CTCF: master weaver of the genome. Cell 137:1194-1211.
40. Pratt WD, Cantello J, Morgan RW, Schat KA. 1994. Enhanced expression of the Marek's disease virus-specific phosphoproteins after stable transfection of MSB-1 cells with the Marek's disease virus homologue of ICP4. Virology 201:132-136.
41. Qian Z, Brunovskis P, Lee L, Vogt PK, Kung HJ. 1996. Novel DNA binding specificities of a putative herpesvirus bZIP oncoprotein. J. Virol. 70:7161-7170.
42. Qian Z, Brunovskis P, Rauscher F, Lee L, Kung HJ. 1995. Transactivation activity of Meq, a Marek's disease herpesvirus bZIP protein persistently expressed in latently infected transformed T cells. J. Virol. 69: 4037-4044.
43. Reddy SM, et al. 2002. Rescue of a pathogenic Marek's disease virus with overlapping cosmid DNAs: use of a pp38 mutant to validate the technology for the study of gene function. Proc. Natl. Acad. Sci. U. S. A. 99:7054-7059.
44. Ross N, et al. 1997. Marek's disease virus EcoRI-Q gene (meq) and a small RNA antisense to ICP4 are abundantly expressed in CD4+ cells and cells carrying a novel lymphoid marker, AV37, in Marek's disease lymphomas. J. Gen. Virol. 78:2191-2198.
45. Schlesinger Y, et al. 2007. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat. Genet. 39:232-236.
46. Sewalt RG, Gunster MJ, van der Vlag J, Satijn DP, Otte AP. 1999. C-terminal binding protein is a transcriptional repressor that interacts with a specific class of vertebrate Polycomb proteins. Mol. Cell. Biol. 19: 777-787.
47. Shi Y, et al. 2003. Coordinated histone modifications mediated by a CtBP co-repressor complex. Nature 422:735-738.
48. Splinter E, et al. 2006. CTCF mediates long-range chromatin looping and local histone modification in the β-globin locus. Genes Dev. 20: 2349-2354.
49. Suchodolski PF, et al. 2009. Homodimerization of Marek's disease virusencoded Meq protein is not sufficient for transformation of lymphocytes in chickens. J. Virol. 83:859-869.
50. Suchodolski PF, et al. 2010. Both homo and heterodimers of Marek's disease virus encoded Meq protein contribute to transformation of lymphocytes in chickens. Virology 399:312-321.
51. Toth Z, et al. 2010. Epigenetic analysis of KSHV latent and lytic genomes. PLoS Pathog. 6:e1001013.
52. Touitou R, et al. 2001. Physical and functional interactions between the corepressor CtBP and the Epstein-Barr virus nuclear antigen EBNA3C. J. Virol. 75:7749-7755.
53. Trapp S, et al. 2006. A virus-encoded telomerase RNA promotes malignant T cell lymphomagenesis. J. Exp. Med. 203:1307-1317.
54. Venugopal K. 2000. Marek's disease: an update on oncogenic mechanisms and control. Res. Vet. Sci. 69:17-23.
55. Xing Z, Xie Q, Morgan RW, Schat KA. 1999. A monoclonal antibody to ICP4 of MDV recognizing ICP4 of serotype 1 and 3 MDV strains. Acta Virol. 43:113-120.
56. Yao Y, et al. 2007. Marek's disease virus type 2 (MDV-2)-encoded microRNAs show no sequence conservation with those encoded by MDV-1. J. Virol. 81:7164-7170.
57. Zhao Y, et al. 2011. Critical role of the virus-encoded microRNA-155 ortholog in the induction of Marek's disease lymphomas. PLoS Pathog. 7:e1001305.